Prevalence of Polycystic Ovarian Syndrome in Alkhoms City, Libya: A Cross-sectional study

Polycystic Ovarian Syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. This study investigates the prevalence of PCOS, focusing on patient-related and disease-related factors. A cross-sectional survey was conducted to explore obstetricians' and gynecologists' perspectives on the diagnosis, prevalence, and management of PCOS. A total of 35 specialists, each with at least three years of clinical experience, participated. The survey included open-ended questions covering patient-related factors (e.g., symptoms, lifestyle) and disease-related aspects (e.g., prevalence, diagnostic methods, treatment). Data were collected through face-to-face interviews from January to April 2022, ensuring confidentiality and standardized procedures to minimize bias. This study analyzed PCOS's prevalence, etiology, symptoms, diagnosis, and treatment. The highest prevalence (62.9%) was observed in the 20–29 age group, declining with age. Unknown causes accounted for 51.42% of cases, followed by hormonal and genetic factors (41.42% each). Menstrual irregularity (80%) was the most common symptom. Ultrasound was the primary diagnostic tool (82.85%), while metformin was the most prescribed treatment (71.42%). PCOS was the most prevalent condition among gynecological disorders (57.14%). These findings highlight the significant burden of PCOS and the need for improved management strategies. Our study concluded that the PCOS remains a significant health concern both globally and within Libya. Highlights the necessity for heightened awareness, early screening, and tailored management strategies. Further research is warranted to explore the underlying causes of regional prevalence variations and to develop culturally appropriate interventions that address the unique needs of the Libyan female population.